Charles River Laboratories International inc (CRL) - News Archive

Charles River and Akron Bio Collaborate to Integrate CGMP Cytokines into Cell Therapy Platform WILMINGTON, Mass. In a strategic move to enhance operational capabilities and address the growing demands of the cell therap...

In recent weeks, Charles River Laboratories International Inc. s (CRL) stock has been struggling significantly, trailing behind the overall market performance. Several key factors are contributing to this slip, particul...

---The stock market is experiencing a robust surge this Wednesday, August 7, 2024. Multiple industries are contributing to this bullish sentiment while a few sectors are struggling.

Revolutionizing Industries: Stock Strategies and Health Solutions Intersect in a Changing Market Landscape In an era where financial markets are increasingly intertwined with technological advancements and health soluti...

WILMINGTON, Mass. In a significant move for the biotechnology field, Charles River Laboratories International, Inc. (NYSE: CRL) and AAVantgarde have entered into a contract development and manufacturing organization (CD...

In recent news, the iShares iBoxx $ Investment Grade Corporate Bond ETF has witnessed a notable shift in its short interest. Short interest refers to the total number of shares of a security that have been sold short an...

Charles River Laboratories International, Inc. (NYSE: CRL), a prominent name in the domain of cell and gene therapy contract development and manufacturing organizations (CDMOs), has announced an innovative collaboration...

In a groundbreaking collaboration aimed at advancing the field of gene-modified cell therapy, Charles River Laboratories International, Inc. (NYSE: CRL) and Captain T Cell, a prominent spinoff from the prestigious Max D...

Johnson Fistel, LLP Investigates Charles River Laboratories Directors and Officers for Breach of Fiduciary DutiesSan Diego, June 06, 2024 - Johnson Fistel, LLP, a shareholder rights law firm, has launched an investigati...

Streamlining Cell and Gene Therapy Research and Development: Charles River Launches Reference Materials for Viral VectorsWILMINGTON, Mass. - Charles River Laboratories International, Inc. (NYSE: CRL) announced today the...

Leading contract research organization, Charles River Laboratories International, Inc., continues to make innovative strides in environmental, social, and governance (ESG) initiatives, strategic collaborations, and corp...

Charles River Expands Alliances in Gene Therapy Manufacturing, Strengthening Capabilities and ServicesIn a move that further solidifies its position in the field of gene therapy manufacturing, Charles River Laboratories...

Charles River Laboratories and Navega Therapeutics Enter Collaboration for Gene Therapy ManufacturingWILMINGTON, Mass. - Charles River Laboratories International, Inc. and Navega Therapeutics, Inc. have announced a comp...

Charles River Laboratories and Wheeler Bio Join Forces to Enhance Biotech Manufacturing CapabilitiesWILMINGTON, Mass. & OKLAHOMA CITY Charles River Laboratories International, Inc., a leading contract research organizat...

In a recent announcement, Charles River Laboratories International, Inc. has entered into a collaboration agreement with Pluristyx Inc., a renowned provider of tools, technologies, and services for cell therapy developm...

Charles River Laboratories Introduces Groundbreaking Animal-Free Bacterial Endotoxin TestCharles River Laboratories International, Inc. has made a significant breakthrough in the field of bacterial endotoxin testing (BE...

Charles River Laboratories Launches Innovative Plasmid Offering to Enhance Gene Therapy Manufacturing Efficiency in Collaboration with Genetic Cures for KidsWILMINGTON, Mass. - Charles River Laboratories International,...

In a significant step forward for cell therapy manufacturing, Charles River Laboratories International, Inc. (NYSE: CRL) and Vertex Pharmaceuticals have announced an important milestone in their strategic collaboration....

Charles River Laboratories and Genetic Cures for Kids Join Forces in Groundbreaking Gene Therapy Manufacturing CollaborationWILMINGTON, Mass. - Charles River Laboratories International, Inc. (NYSE: CRL) and Genetic Cure...

Charles River Expands Suite of Cellular Products with CliniPrime Cryopreserved Leukopaks, While Facing Revenue Growth ChallengesCharles River Laboratories International, Inc. (NYSE: CRL), a leading provider of drug disc...